Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.42 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.